Christopher Toth - Siemens Healthineers Head Varian
| SMMNY Stock | USD 28.65 0.32 1.10% |
Insider
Christopher Toth is Head Varian of Siemens Healthineers AG
| Age | 44 |
| Phone | 49 9131 84 3385 |
| Web | https://www.siemens-healthineers.com |
Christopher Toth Latest Insider Activity
Tracking and analyzing the buying and selling activities of Christopher Toth against Siemens Healthineers pink sheet is an integral part of due diligence when investing in Siemens Healthineers. Christopher Toth insider activity provides valuable insight into whether Siemens Healthineers is net buyers or sellers over its current business cycle. Note, Siemens Healthineers insiders must abide by specific rules, including filing SEC forms every time they buy or sell Siemens Healthineers'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Christopher Toth over a month ago Disposition of 25372 shares by Christopher Toth of Baxter International at 32.56 subject to Rule 16b-3 |
Siemens Healthineers Management Efficiency
The company has return on total asset (ROA) of 0.0383 % which means that it generated a profit of $0.0383 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1129 %, meaning that it generated $0.1129 on every $100 dollars invested by stockholders. Siemens Healthineers' management efficiency ratios could be used to measure how well Siemens Healthineers manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Wilfried Freudenberg | CSL | N/A | |
| Marco Catalani | Essilor International SA | N/A | |
| Jemimah Brennan | CSL | N/A | |
| MS BA | CSL | 53 | |
| Stefano Grassi | Essilor International SA | 50 | |
| Dirk Toepfer | Merck KGaA ADR | N/A | |
| Friederike Rotsch | Merck KGaA ADR | 51 | |
| Toshiya Sasai | Chugai Pharmaceutical Co | N/A | |
| Barbara Weiland | Merck KGaA ADR | 49 | |
| Masahiko Uchida | Chugai Pharmaceutical Co | N/A | |
| Peter Guenter | Merck KGaA ADR | 61 | |
| Taishi Arashida | Hoya Corp | N/A | |
| Francesco Milleri | Essilor International SA | 64 | |
| Augustine JD | Hoya Corp | 55 | |
| Paul BA | CSL | 66 | |
| Belen MD | Merck KGaA ADR | 63 | |
| BCom BComm | CSL | 57 | |
| Christina Hickie | CSL | N/A | |
| BS BS | CSL | 61 | |
| Gerhard Schmitz | Merck KGaA ADR | 60 | |
| Tomoko Nakagawa | Hoya Corp | N/A | |
Management Performance
| Return On Equity | 0.11 | |||
| Return On Asset | 0.0383 |
Siemens Healthineers Leadership Team
Elected by the shareholders, the Siemens Healthineers' board of directors comprises two types of representatives: Siemens Healthineers inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Siemens. The board's role is to monitor Siemens Healthineers' management team and ensure that shareholders' interests are well served. Siemens Healthineers' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Siemens Healthineers' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Andre Hartung, Head Imaging | ||
| Christian Klaussner, Ex Fin | ||
| Carsten Bertram, Head Therapies | ||
| Bernhard Montag, President of the Management Board, CEO | ||
| Christopher Toth, Head Varian | ||
| Darleen Caron, Labor Officer | ||
| Marc Koebernick, Head Relations | ||
| Michel DVM, Pres Therapies | ||
| Jochen Schmitz, CFO, Member of the Managing Board | ||
| Elisabeth Staudinger, Member Board |
Siemens Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Siemens Healthineers a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.11 | |||
| Return On Asset | 0.0383 | |||
| Profit Margin | 0.09 % | |||
| Operating Margin | 0.13 % | |||
| Current Valuation | 59.39 B | |||
| Shares Outstanding | 2.24 B | |||
| Price To Earning | 28.75 X | |||
| Price To Book | 3.16 X | |||
| Price To Sales | 2.66 X | |||
| Revenue | 21.71 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Siemens Pink Sheet Analysis
When running Siemens Healthineers' price analysis, check to measure Siemens Healthineers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Siemens Healthineers is operating at the current time. Most of Siemens Healthineers' value examination focuses on studying past and present price action to predict the probability of Siemens Healthineers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Siemens Healthineers' price. Additionally, you may evaluate how the addition of Siemens Healthineers to your portfolios can decrease your overall portfolio volatility.